Table 1.
Conditions for penetration studies of drug solutions and NPs
Order number | APIs | Drug form | Donor cell | Receiver cell | Duration |
---|---|---|---|---|---|
1 | LD | Free drug | Supersaturation in IPM, 3 mL | PBS (pH =7.4), 3 mL | 8 h |
2 | IM | Free drug | Supersaturation in IPM, 3 mL | PBS (pH =7.4), 3 mL | 8 h |
3 | 5-FU | Free drug | Supersaturation in IPM, 3 mL | PBS (pH =7.4), 3 mL | 8 h |
4 | Cur | Free drug | Suspended in gel, 0.25 mg/mL, 2 g | 20% ethanol–water, 8 mL | 24 h |
5 | Cur | 50 nm NPs | NPs in gel, 0.25 mg/mL, 2 g | 20% ethanol–water, 8 mL | 24 h |
6 | Cur | 150 nm NPs | NPs in gel, 0.25 mg/mL, 2 g | 20% ethanol–water, 8 mL | 24 h |
Note: The experiments were performed at 32°C.
Abbreviations: 5-FU, 5-fluorouracil; APIs, active pharmaceutical ingredients; Cur, curcumin; IM, indomethacin; IPM, isopropyl myristate; LD, lidocaine; NPs, nanoparticles.